NL
SNDX icon

NVWM LLC’s Syndax Pharmaceuticals SNDX Stock Holding History

NVWM LLC’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,475
Closed -$818K – 695
2024
Q3 		$818K Sell
42,475
-225
-0.5% -$4.65K 0.21% 145
2024
Q2 		$877K Sell
42,700
-262
-0.6% -$5.48K 0.23% 135
2024
Q1 		$1.02M Buy
+42,962
New +$958K 0.28% 110

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

NVWM LLC's SNDX Position: Q4 2024 in Review

NVWM LLC sold out of Syndax Pharmaceuticals (SNDX) in Q4 2024, closing a stake of 42,475 shares — an estimated $818K sold.

NVWM LLC first reported a position in SNDX in Q1 2024 and held it in 3 quarters. The position peaked at $1.02M in Q1 2024. 215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

  • NVWM LLC reported no remaining Syndax Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • NVWM LLC sold 42,475 Syndax Pharmaceuticals shares in Q4 2024, an estimated $818K.
  • NVWM LLC first reported a position in Syndax Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • NVWM LLC's Syndax Pharmaceuticals position peaked at $1.02M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on NVWM LLC's 13F filing for Q4 2024, filed 27 Jan 2025.